Pancreatic cancer patients now have a new treatment option in the United States.
Lynparza has been approved by the Food and Drug Administration for the prevention management of the disease. The medicine is already being used for the treatment of ovarian and breast cancer.
The drug is approved for patients with pancreatic cancer whose cancers have not grown following treatment for at least 16 weeks.
Producers of the drug, AstraZeneca, and Merck say pancreatic cancer is the 12th most common type of disease, but it is the third-largest cause of cancer mortality in the U.S. That’s because it is often not detected until it is in advanced stages.
On Sunday, the civil rights activist and lawmaker John Lewis revealed that he had been diagnosed with stage four pancreatic cancer.